Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment.

The potential for interaction between pacemakers and implantable cardioverter/ defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.

[1]  J. Mugica,et al.  Study of Interactions Between Permanent Pacemakers and Electronic Antitheft Surveillance Systems , 2000, Pacing and clinical electrophysiology : PACE.

[2]  D P Zipes,et al.  Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. , 1999, Circulation.

[3]  V Barbaro,et al.  Electromagnetic Interference of Digital and Analog Cellular Telephones with Implantable Cardioverter Defibrillators: In Vitro and In Vivo Studies , 1999, Pacing and clinical electrophysiology : PACE.

[4]  C. Carnes,et al.  Drug and Defibrillator Interactions , 1998, Pharmacotherapy.

[5]  D. Benditt,et al.  Digital cellular telephone interaction with implantable cardioverter-defibrillators. , 1998, Journal of the American College of Cardiology.

[6]  F. Marchlinski,et al.  ICD‐Antiarrhythmic Drug and ICD‐Pacemaker Interactions , 1997, Journal of cardiovascular electrophysiology.

[7]  Rebecca A. Steffens,et al.  Interference with cardiac pacemakers by cellular telephones. , 1997, The New England journal of medicine.

[8]  W. Irnich,et al.  Electromagnetic Interference of Pacemakers by Mobile Phones , 1996, Pacing and clinical electrophysiology : PACE.

[9]  B. Lüderitz,et al.  Interactions between drugs and devices: experimental and clinical studies. , 1994, American heart journal.

[10]  R. Boccadamo,et al.  Effects of Oral Propafenone Therapy on Chronic Myocardial Pacing Threshold , 1992, Pacing and clinical electrophysiology : PACE.

[11]  S. Laniado,et al.  The Effect of Metal Detector Gates on Implanted Permanent Pacemakers , 1988, Pacing and clinical electrophysiology : PACE.

[12]  P. Kowey,et al.  Effect of Antiarrhythmic Drugs on Defibrillation Threshold: Case Report of an Adverse Effect of Mexiletine and Review of the Literature , 1988, Pacing and clinical electrophysiology : PACE.

[13]  C. Kerr,et al.  Failure to Pace following High Dose Antiarrhythmic Therapy—Reversal with Isoproterenol , 1984, Pacing and clinical electrophysiology : PACE.

[14]  A. Camm,et al.  Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds. , 1984, The American journal of cardiology.

[15]  A. Camm,et al.  Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds , 1983, Pacing and clinical electrophysiology : PACE.

[16]  Y. Gilboa,et al.  Exit Block in Myxedema, Treated Effectively by Thyroid Hormone Therapy , 1980, Pacing and clinical electrophysiology : PACE.

[17]  G. Tyers,et al.  Effects of acid-base imbalance on myocardial pacing thresholds. , 1975, The Journal of thoracic and cardiovascular surgery.

[18]  E. Sowton,et al.  Influence of beta-blockade on myocardial threshold in patients with pacemakers. , 1970, Lancet.

[19]  B. Lucchesi,et al.  Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. , 1967, American heart journal.

[20]  F G Shellock,et al.  Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system. , 1999, AJR. American journal of roentgenology.

[21]  D. Zipes,et al.  Surveillance Systems and Implantable Cardioverter-Defibrillators , 1999 .

[22]  M E McIvor,et al.  Study of Pacemaker and Implantable Cardioverter Defibrillator Triggering by Electronic Article Surveillance Devices (SPICED TEAS) , 1998, Pacing and clinical electrophysiology : PACE.